Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in Italy
9 of 42 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms
- Where
- Milan
- Age
- 16 years and over
- People
- 1,190
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07863466 - No phaseTaking peopleObservational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
- Where
- Alessandria, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Cuneo, Ferrara, Florence, Messina, Mestre, Milan, Monza, Naples, Novara, Padova, Palermo, Pavia, Pisa, Roma, San Giovanni Rotondo, Torino, Trieste, Udine, Varese, Verona, Vicenza
- Age
- 18 years to 100 years
- People
- 429 worldwide
- Run by
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
See details and how to joinNCT06506084 - No phaseTaking peopleClinical Epidemiology in Contemporary Patients With Myelofibrosis.
- Where
- Alessandria, Bergamo, Bologna, Catania, Florence, Milan, Monza, Naples, Novara, Pavia, Roma, Torino, Tricase, Verona, Vicenza
- Age
- 18 years to 100 years
- People
- 617 worldwide
- Run by
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
See details and how to joinNCT06533813 - No phaseTaking peopleA ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
- Where
- Alessandria, Bergamo, Bologna, Brescia, Florence, Milan, Monza, Naples, Novara, Pavia, Pescara, Roma, Verona, Vicenza
- Age
- 18 years to 100 years
- People
- 678 worldwide
- Run by
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
See details and how to joinNCT07203768 - No phaseNot yet taking people in ItalyCRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA)
- Where
- Pescara, Torino
- Age
- 18 years and over
- People
- 50
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07645755 - No phaseTaking peopleUnveiling the Germline Predisposition to Myeloproliferative Neoplasms
- Where
- Pavia
- Age
- 18 years and over
- People
- 313
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT07204392 - No phaseTaking peopleRole of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells
- Where
- Pavia
- Age
- 18 years and over
- People
- 10
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06896344 - No phaseTaking peopleRuxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
- Where
- Bologna, Cagliari, Catania, Cosenza, Ferrara, Genoa, Milan, Monza, Naples, Padova, Parma, Pesaro, Piacenza, Ravenna, Reggio Calabria, Rimini, Rome, Siena, Turin, Udine, Verona, Viterbo
- Age
- 18 years and over
- People
- 1,055
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06516406 - No phaseTaking peopleEvaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.
- Where
- Bari, Bologna, Brescia, Catania, Naples, Roma, Torino, Udine, Verona, Viterbo
- Age
- 18 years to 99 years
- People
- 500
- Run by
- University of Milano Bicocca
See details and how to joinNCT05553873